Profile data is unavailable for this security.
About the company
McKesson Corporation is a diversified healthcare services provider. The Company is focused on advancing health outcomes for patients everywhere. It operates its business through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter (OTC) pharmaceutical drugs, and other healthcare-related products. Its Prescription Technology Solutions segment serves its biopharma and life sciences partners and patients. Its Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. Its International segment provides distribution and services to wholesale, institutional, and retail customers in 11 European countries and Canada.
- Revenue in USD (TTM)268.45bn
- Net income in USD1.40bn
- Incorporated1994
- Employees58.00k
- LocationMckesson Corp6555 State Highway 161IRVING 75039United StatesUSA
- Phone+1 (972) 446-4800
- Fax+1 (302) 636-5454
- Websitehttps://www.mckesson.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alnylam Pharmaceuticals, Inc. | 884.25m | -980.72m | 26.81bn | 1.67k | -- | 159.45 | -- | 31.49 | -8.17 | -8.17 | 7.37 | 1.45 | 0.2586 | 1.69 | 7.19 | 531,078.10 | -28.68 | -32.56 | -34.85 | -37.94 | 83.40 | -- | -110.91 | -223.64 | 3.62 | -2.99 | 0.7938 | -- | 71.31 | 78.07 | 0.6358 | -- | 3.42 | -- |
| DuPont de Nemours Inc | 15.14bn | 1.23bn | 29.37bn | 28.00k | 25.39 | 1.19 | 11.47 | 2.01 | 2.39 | 3.65 | 29.38 | 50.96 | 0.3354 | 3.96 | 5.94 | 540,642.90 | 2.87 | -0.2227 | 3.25 | -0.289 | 34.63 | 31.60 | 8.56 | -1.61 | 2.12 | 5.06 | 0.3016 | -- | 16.15 | -19.13 | 172.14 | -15.09 | -25.20 | -26.30 |
| AmerisourceBergen Corp. | 236.33bn | 1.84bn | 29.99bn | 38.00k | 16.71 | 134.91 | 11.97 | 0.1277 | 8.71 | 8.71 | 1,117.75 | 1.08 | 4.18 | 14.80 | 12.09 | 6,219,087.00 | 3.19 | 0.1634 | 12.15 | 0.6614 | 3.49 | 2.89 | 0.7635 | 0.0365 | 0.5543 | 12.43 | 0.9213 | 473.09 | 12.69 | 7.82 | 145.18 | 1.52 | -1.16 | 5.29 |
| Seagen Inc | 1.78bn | -739.80m | 32.39bn | 2.68k | -- | 11.04 | -- | 18.22 | -4.04 | -4.04 | 9.70 | 15.91 | 0.4689 | 1.50 | 4.35 | 664,625.40 | -19.51 | -5.22 | -22.62 | -6.00 | 79.58 | 87.67 | -41.61 | -9.78 | 4.04 | -211.85 | 0.00 | -- | -27.63 | 30.36 | -209.91 | -- | 13.46 | -- |
| Iqvia Holdings Inc | 14.14bn | 1.16bn | 43.38bn | 82.00k | 40.03 | 8.36 | 19.55 | 3.16 | 5.99 | 5.99 | 72.98 | 28.68 | 0.5847 | -- | 5.71 | 178,936.70 | 4.81 | 1.77 | 6.06 | 2.14 | 34.42 | 34.30 | 8.23 | 3.64 | -- | 4.95 | 0.7046 | 0.00 | 22.14 | 15.28 | 246.24 | 68.08 | 31.30 | -- |
| McKesson Corporation | 268.45bn | 1.40bn | 50.99bn | 58.00k | 38.25 | -- | 22.94 | 0.1925 | 9.40 | 9.40 | 1,782.81 | -13.92 | 4.29 | 12.92 | 13.39 | 4,628,380.00 | 2.50 | -0.7548 | 9.44 | -2.38 | 4.89 | 5.24 | 0.5822 | -0.2014 | 0.5483 | 43.92 | 1.34 | -- | 10.80 | 5.86 | 124.66 | -26.44 | -0.9799 | 9.71 |
| Moderna Inc | 23.00bn | 14.06bn | 66.95bn | 2.70k | 5.31 | 3.80 | 4.75 | 2.96 | 32.80 | 32.80 | 53.79 | 45.88 | 1.09 | 3.18 | 9.76 | 8,516,667.00 | 66.62 | 41.17 | 105.90 | 66.78 | 82.29 | -- | 61.12 | 52.35 | 1.71 | -- | 0.0407 | 0.00 | 2,199.12 | 179.44 | 1,733.33 | -- | 53.67 | -- |
| Regeneron Pharmaceuticals Inc | 14.23bn | 5.69bn | 67.82bn | 10.37k | 12.81 | 3.40 | 11.69 | 4.92 | 50.07 | 50.07 | 125.24 | 188.93 | 0.5844 | 1.02 | 2.34 | 1,372,184.00 | 23.36 | 25.64 | 27.13 | 29.99 | 84.97 | 88.51 | 39.97 | 39.11 | 4.39 | 11.87 | 0.1155 | -- | 89.14 | 27.02 | 129.86 | 55.24 | 1.52 | -- |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Jun 2022 | 14.62m | 10.18% |
| BlackRock Fund Advisorsas of 30 Jun 2022 | 6.60m | 4.60% |
| SSgA Funds Management, Inc.as of 31 Mar 2022 | 6.54m | 4.56% |
| Massachusetts Financial Services Co.as of 30 Jun 2022 | 4.90m | 3.41% |
| JPMorgan Investment Management, Inc.as of 30 Jun 2022 | 4.80m | 3.34% |
| Berkshire Hathaway, Inc. (Investment Management)as of 31 Mar 2022 | 2.92m | 2.04% |
| Geode Capital Management LLCas of 30 Jun 2022 | 2.52m | 1.75% |
| Pzena Investment Management LLCas of 30 Jun 2022 | 2.43m | 1.70% |
| Putnam Investment Management LLCas of 31 Mar 2022 | 2.30m | 1.60% |
| Fidelity Management & Research Co. LLCas of 30 Jun 2022 | 2.09m | 1.46% |
